Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis
Clinical trial NCT02273765 · COMPLETED
Trial details
- NCT number
- NCT02273765
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-11
- Primary completion
- 2018-11-28
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.